Radiotherapeutic Strategies in Management of Brain Metastasis

Brain metastasis may occur in 10-30% of all cancer patients, and the prognosis is generally poor, with median survival of only a few months. Treatments can vary widely, ranging from close observation to multimodality therapy including surgery, radiation and even chemotherapy. An understanding of the radiotherapy treatment options should help physicians in managing the overall care of their patients.

Target Audience

This activity is targeted to radiation oncologists, medical oncologists, surgical oncologists, neuro-oncologists, family medicine, generalists, radiation therapists, residents, and medical students.  

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Describe the radiotherapeutic treatment options and survival outcomes for brain metastasis
  • Explain the prognostic indicators and side effects that may impact patient response to treatment and quality of life
  • Make appropriate treatment recommendations based on understanding of patient prognosis
  • Discuss the emerging treatment technologies

 

Accreditation Statement

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement

The University of Texas Southwestern Medical Center designates this enduring material activity for a maximum of 0.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course summary
Available credit: 
  • 0.50 AMA
  • 0.50 Attendance
Course opens: 
08/11/2014
Course expires: 
09/30/2015
Cost:
$0.00
COURSE DIRECTOR
Hak Choy, M.D.
The Nancy B. & Jake L. Hamon Distinguished Chair in Therapeutic Oncology Research
Professor of Radiation Oncology
UT Southwestern Medical Center
Dallas, Texas
Disclosure:  Nothing to disclose
 
AUTHOR
Kevin Choe, M.D., Ph.D.
Assistant Professor of Radiation Oncology
UT Southwestern Medical Center
Dallas, Texas
Disclosure:  Nothing to disclose
 
PROGRAM COORDINATOR
Dee Hill
Program Coordinator
UT Southwestern Medical Center
Dallas, Texas
Disclosure: Nothing to disclose

Available Credit

  • 0.50 AMA
  • 0.50 Attendance

Accreditation Period

Course opens: 
08/11/2014
Course expires: 
09/30/2015

Price

Cost:
$0.00
Please login or create an account to take this course.